Deciphering the Self-antigen Specific T Cell Signature of Autoimmune Liver Diseases

NCT07784881 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 220

Last updated 2026-09-01

No results posted yet for this study

Summary

The study aims to establish the molecular signature of autoimmune self-antigen-specific T cells in AutoImmune Liver Disease (AILD)

Conditions

  • Autoimmune Hepatitis
  • Primary Biliary Cholangitis (PBC)
  • Autoimmune Liver Disease
  • Primary Sclerosing Cholangitis (PSC)

Sponsors & Collaborators

  • Nantes University Hospital

    lead OTHER

Principal Investigators

  • Jérôme Gournay · Nantes University Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-20
Primary Completion
2025-10-24
Completion
2025-10-24

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07784881 on ClinicalTrials.gov